Evidence map›Paper›PMID 34201741›Full record

ArticleBiomedicines2021

miR-208b Reduces the Expression of Kcnj5 in a Cardiomyocyte Cell Line.

Julia Hupfeld, Maximilian Ernst, Maria Knyrim, Stephanie Binas, Udo Kloeckner, Sindy Rabe, Katja Quarch, Danny Misiak, Matthew Fuszard, Claudia Grossmann and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Epigenetic Mechanisms in Heart Diseases.Reviews in cardiovascular medicine · 2025
    Review
  4. Article
  5. Cardiac microRNAs: diagnostic and therapeutic potential.Archives of medical science : AMS · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Julia HupfeldJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.
Maximilian ErnstJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.
Maria KnyrimJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.
Stephanie BinasJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.
Udo KloecknerJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.
Sindy RabeJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.
Katja QuarchJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.
Danny MisiakInstitute of Molecular Medicine, Medical Faculty of the Martin Luther University Halle-Wittenberg, Charles Tanford Protein Center, 06120 Halle (Saale), Germany.ORCID 0000-0001-5931-8425
Matthew FuszardZentrum für Medizinische Grundlagenforschung, Core Facility-Proteomic Mass Spectrometry, Proteinzentrum Charles Tanford, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Claudia GrossmannJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.
Michael GekleJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.ORCID 0000-0002-1581-8767
Barbara SchreierJulius-Bernstein Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, 06112 Halle (Saale), Germany.
Martin Luther University Halle-Wittenberg · DE

Funding

Deutsche Forschungsgemeinschaft Ge905/19Deutsche Forschungsgemeinschaft RTG 1591
6 · The paper itself

Abstract

MicroRNAs (miRs) contribute to different aspects of cardiovascular pathology, among them cardiac hypertrophy and atrial fibrillation. Cardiac miR expression was analyzed in a mouse model with structural and electrical remodeling. Next-generation sequencing revealed that miR-208b-3p was ~25-fold upregulated. Therefore, the aim of our study was to evaluate the impact of miR-208b on cardiac protein expression. First, an undirected approach comparing whole RNA sequencing data to miR-walk 2.0 miR-208b 3'-UTR targets revealed 58 potential targets of miR-208b being regulated. We were able to show that miR-208b mimics bind to the 3' untranslated region (UTR) of voltage-gated calcium channel subunit alpha1 C and Kcnj5, two predicted targets of miR-208b. Additionally, we demonstrated that miR-208b mimics reduce GIRK1/4 channel-dependent thallium ion flux in HL-1 cells. In a second undirected approach we performed mass spectrometry to identify the potential targets of miR-208b. We identified 40 potential targets by comparison to miR-walk 2.0 3'-UTR, 5'-UTR and CDS targets. Among those targets, Rock2 and Ran were upregulated in Western blots of HL-1 cells by miR-208b mimics. In summary, miR-208b targets the mRNAs of proteins involved in the generation of cardiac excitation and propagation, as well as of proteins involved in RNA translocation (Ran) and cardiac hypertrophic response (Rock2).

Indexed as

cardiomyocytesheartKcnj5miR-208bRanRock2

Identifiers

PMID34201741
PMCPMC8301481
OpenAlexW3177487858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.